Close
  Indian J Med Microbiol
 

Figure 1: Quick Inventory of Depressive Symptomatology scores at each repetitive transcranial magnetic stimulation session throughout patient’s treatment in 2020 and 2021. Note:* indicates the point at which dextroamphetamine-amphetamine extended-release was completely discontinued. # indicates the point at which liothyronine was started due to patient’s low thyroxine levels.

<b>Figure 1:</b> Quick Inventory of Depressive Symptomatology scores at each repetitive transcranial magnetic stimulation session throughout patient’s treatment in 2020 and 2021.</b> Note:* indicates the point at which dextroamphetamine-amphetamine extended-release was completely discontinued. # indicates the point at which liothyronine was started due to patient’s low thyroxine levels.